Product Information

MYCOPHENOLATE 250 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1347 per EA under NDC 31722087801. Its NADAC has been published 80 times since May 7, 2025.

FDA first approved this application on Oct 22, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MYCOPHENOLATE 250 MG CAPSULE

Mycophenolate Mofetil
$0.1347per EA

Strength

250 mg/1

NDC

31722087801

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

MYCOPHENOLATE MOFETIL

Approval Type

Generic (ANDA)

FDA Application

ANDA207022

FDA Approved

10/22/2024

TE Code

AB

On Market Since

10/22/2024

Pharmacological Classes

Price Statistics

The NADAC for MYCOPHENOLATE 250 MG CAPSULE has been published 80 times since May 7, 2025, and over the history we have for it it has declined 18.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1347 per EA
All-time high$0.1659 (May 14, 2025)
All-time low$0.1331 (Sep 17, 2025)
52-week high$0.1452
52-week low$0.1347
Median price$0.1403
Average price$0.1427
Largest weekly change-7.5% (Jul 23, 2025)
Weeks tracked80
Tracking sinceMay 7, 2025

Price History

1W

0.0%

1M

-2.5%

3M

-2.8%

6M

-4.6%

1Y

-2.4%

3Y

N/A

5Y

N/A

All

-18.8%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MYCOPHENOLATE 250 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLATE 250 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.1347 per EA (NDC 31722087801), effective Nov 11, 2026.

How has the price of MYCOPHENOLATE 250 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for MYCOPHENOLATE 250 MG CAPSULE has declined 18.8%. It has been tracked across 80 weekly CMS publications since May 7, 2025.

What are the highest and lowest recorded NADAC prices for MYCOPHENOLATE 250 MG CAPSULE?

Since May 7, 2025, the NADAC for MYCOPHENOLATE 250 MG CAPSULE has ranged from a low of $0.1331 (Sep 17, 2025) to a high of $0.1659 (May 14, 2025), with a median of $0.1403 per EA.

Are there cheaper alternatives to MYCOPHENOLATE 250 MG CAPSULE?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MYCOPHENOLATE 250 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures MYCOPHENOLATE 250 MG CAPSULE?

MYCOPHENOLATE 250 MG CAPSULE (NDC 31722087801) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.